First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular carcinoma (HCC).
| Autor: | Reig, Maria, Evans, T.R. Jeffry, Chon, Hong Jae, Lim, Ho Yeong, Ryu, Min-Hee, Kim, Do Young, Macarulla, Teresa, Gomez-Martin, Carlos, Moreno, Victor, Haugk, Beate, Ness, Thomas, Baumann, Pia, Bhoi, Sujata, Jensen, Malene, Tunblad, Karin, Wallberg, Hans, Oberg, Fredrik, Heo, Jeong |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p476-476, 151p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|